<VariationArchive VariationID="1451911" VariationName="NM_001365088.1(SLC12A6):c.2962_2963dup (p.Glu989fs)" VariationType="Duplication" Accession="VCV001451911" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1438671" VariationID="1451911">
      <GeneList>
        <Gene Symbol="SLC12A6" FullName="solute carrier family 12 member 6" GeneID="9990" HGNC_ID="HGNC:10914" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q14</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="34229784" stop="34338057" display_start="34229784" display_stop="34338057" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NW_025791798.1" start="3625" stop="76798" display_start="3625" display_stop="76798" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="34522196" stop="34630264" display_start="34522196" display_stop="34630264" Strand="-" />
          </Location>
          <OMIM>604878</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001365088.1(SLC12A6):c.2962_2963dup (p.Glu989fs)</Name>
      <CanonicalSPDI>NC_000015.10:34236786:TA:TATA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>15q14</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="34236786" stop="34236787" display_start="34236786" display_stop="34236787" variantLength="2" positionVCF="34236786" referenceAlleleVCF="G" alternateAlleleVCF="GTA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="34528987" stop="34528988" display_start="34528987" display_stop="34528988" variantLength="2" positionVCF="34528987" referenceAlleleVCF="G" alternateAlleleVCF="GTA" />
      </Location>
      <OtherNameList>
        <Name>NM_001365088.1(SLC12A6):c.2962_2963dup</Name>
        <Name>p.Glu989fs</Name>
      </OtherNameList>
      <ProteinChange>E938fs</ProteinChange>
      <ProteinChange>E989fs</ProteinChange>
      <ProteinChange>E980fs</ProteinChange>
      <ProteinChange>E930fs</ProteinChange>
      <ProteinChange>E974fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.34236787_34236788dup" Assembly="GRCh38">
            <Expression>NC_000015.10:g.34236787_34236788dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.34528988_34528989dup" Assembly="GRCh37">
            <Expression>NC_000015.9:g.34528988_34528989dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007951.1" sequenceAccession="NG_007951" sequenceVersion="1" change="g.106277_106278dup">
            <Expression>NG_007951.1:g.106277_106278dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042494.2" sequenceAccession="NM_001042494" sequenceVersion="2" change="c.2785_2786dup">
            <Expression>NM_001042494.2:c.2785_2786dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035959.1" sequenceAccession="NP_001035959" sequenceVersion="1" change="p.Glu930fs">
            <Expression>NP_001035959.1:p.Glu930fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042495.2" sequenceAccession="NM_001042495" sequenceVersion="2" change="c.2785_2786dup">
            <Expression>NM_001042495.2:c.2785_2786dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035960.1" sequenceAccession="NP_001035960" sequenceVersion="1" change="p.Glu930fs">
            <Expression>NP_001035960.1:p.Glu930fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042496.2" sequenceAccession="NM_001042496" sequenceVersion="2" change="c.2935_2936dup">
            <Expression>NM_001042496.2:c.2935_2936dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035961.1" sequenceAccession="NP_001035961" sequenceVersion="1" change="p.Glu980fs">
            <Expression>NP_001035961.1:p.Glu980fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042497.2" sequenceAccession="NM_001042497" sequenceVersion="2" change="c.2917_2918dup">
            <Expression>NM_001042497.2:c.2917_2918dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035962.1" sequenceAccession="NP_001035962" sequenceVersion="1" change="p.Glu974fs">
            <Expression>NP_001035962.1:p.Glu974fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365088.1" sequenceAccession="NM_001365088" sequenceVersion="1" change="c.2962_2963dup" MANESelect="true">
            <Expression>NM_001365088.1:c.2962_2963dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001352017.1" sequenceAccession="NP_001352017" sequenceVersion="1" change="p.Glu989fs">
            <Expression>NP_001352017.1:p.Glu989fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005135.2" sequenceAccession="NM_005135" sequenceVersion="2" change="c.2809_2810dup">
            <Expression>NM_005135.2:c.2809_2810dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005126.1" sequenceAccession="NP_005126" sequenceVersion="1" change="p.Glu938fs">
            <Expression>NP_005126.1:p.Glu938fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_133647.2" sequenceAccession="NM_133647" sequenceVersion="2" change="c.2962_2963dup">
            <Expression>NM_133647.2:c.2962_2963dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_598408.1" sequenceAccession="NP_598408" sequenceVersion="1" change="p.Glu989fs">
            <Expression>NP_598408.1:p.Glu989fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_270" sequenceAccession="LRG_270">
            <Expression>LRG_270:g.106277_106278dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_270t1" sequenceAccession="LRG_270t1">
            <Expression>LRG_270t1:c.2809_2810dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_270p1" sequenceAccession="LRG_270p1" change="p.Glu938fs">
            <Expression>LRG_270p1:p.Glu938fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2140641550" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001365088.1(SLC12A6):c.2962_2963dup (p.Glu989fs) AND not provided" Accession="RCV001993377" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-02-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001365088.1(SLC12A6):c.2962_2963dup (p.Glu989fs) AND Agenesis of the corpus callosum with peripheral neuropathy" Accession="RCV002563623" Version="3">
        <ClassifiedConditionList TraitSetID="1484">
          <ClassifiedCondition DB="MedGen" ID="C0795950">Agenesis of the corpus callosum with peripheral neuropathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-25" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-01-25" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12368912</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16606917</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1484" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Charlevoix disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Corpus callosum agenesis neuronopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyneuropathy, sensorimotor, with or without agenesis of the corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agenesis of corpus callosum with neuronopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agenesis of corpus callosum with peripheral neuropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agenesis of corpus callosum with polyneuropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HMSN/ACC</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andermann syndrome</ElementValue>
                <XRef ID="Andermann+Syndrome/429" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Agenesis of the corpus callosum with peripheral neuropathy</ElementValue>
                <XRef ID="MONDO:0000902" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ACCPN</ElementValue>
                <XRef Type="MIM" ID="218000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000525862" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525863" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552164" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553541" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000264022" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary motor and sensory neuropathy with agenesis of the corpus callosum (HMSN/ACC), a neurodevelopmental and neurodegenerative disorder, is characterized by severe progressive sensorimotor neuropathy with resulting hypotonia, areflexia, and amyotrophy, and by variable degrees of dysgenesis of the corpus callosum. Mild-to-severe intellectual disability and "psychotic episodes" during adolescence are observed. Sensory modalities are moderately to severely affected beginning in infancy. The average age of onset of walking is 3.8 years; the average age of loss of walking is 13.8 years; the average age of death is 33 years.</Attribute>
                <XRef ID="NBK1372" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1537" />
                <XRef ID="1537" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301546</ID>
                <ID Source="BookShelf">NBK1372</ID>
              </Citation>
              <XRef ID="1496" DB="Orphanet" />
              <XRef ID="C0795950" DB="MedGen" />
              <XRef ID="MONDO:0000902" DB="MONDO" />
              <XRef Type="MIM" ID="218000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6450521" SubmissionDate="2023-01-27" DateLastUpdated="2023-02-07" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="e29001d2-34b1-455c-8511-1733559c643f" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003761343" DateUpdated="2023-02-07" DateCreated="2023-02-07" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The homozygous p.Glu989ThrfsTer5 variant in SLC12A6 was identified by our study in one individual with agenesis of the corpus callosum with peripheral neuropathy. The p.Glu989ThrfsTer5 variant in SLC12A6 has not been previously reported in individuals with agenesis of the corpus callosum with peripheral neuropathy. This variant has also been reported in ClinVar (Variation ID: 1451911) and has been interpreted as pathogenic by Invitae. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein‚Äôs amino acid sequence beginning at position 989 and leads to a premature termination codon 5 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the SLC12A6 gene is strongly associated to autosomal recessive agenesis of the corpus callosum with peripheral neuropathy. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for agenesis of the corpus callosum with peripheral neuropathy. ACMG/AMP Criteria applied: PVS1_Strong, PM2_Supporting, PM3_Supporting (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001365088.1(SLC12A6):c.2962_2963dup</Name>
            <Name>p.Glu989fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.10:g.34236787_34236788dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0000902" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12627697</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4250172" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13050084|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002234492" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12368912</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16606917</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with SLC12A6-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Glu989Thrfs*5) in the SLC12A6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC12A6 are known to be pathogenic (PMID: 12368912, 16606917).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.34528987_34528988insTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4250172" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6450521" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0000902" MappingRef="MONDO">
        <MedGen CUI="C0795950" Name="Agenesis of the corpus callosum with peripheral neuropathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

